Source: Mongeau‐Pérusse, V., Brissette, S., Bruneau, J., Conrod, P., Dubreucq, S., Gazil, G., ... & Jutras‐Aswad, D. (2021). Cannabidiol as a treatment for craving and relapse in individuals with cocaine use disorder: a randomized placebo‐controlled trial. Addiction. ABSTRACT Background and Aims...

Source: Gali, K., Winter, S.J., Ahuja, N.J. et al. Changes in cannabis use, exposure, and health perceptions following legalization of adult recreational cannabis use in California: a prospective observational study. Subst Abuse Treat Prev Policy 16, 16 (2021). https://doi.org/10.1186/s13011-021...

coorelacion entre consumo de cannabis y esquizofrenia

Se hace una breve narrativa acerca de la relacion encontrada entre consumo de cannabis y esquizofrenia

Source: Matheson, J., & Le Foll, B. (2020). Cannabis Legalization and Acute Harm From High Potency Cannabis Products: A Narrative Review and Recommendations for Public Health. Frontiers in Psychiatry, 11, 1017. Abstract Legalization and commercial sale of non-medical cannabis has led to increasing...

Source: Leas EC, Hendrickson EM, Nobles AL, et al. Self-reported Cannabidiol (CBD) Use for Conditions With Proven Therapies. JAMA Netw Open. 2020;3(10):e2020977. doi:10.1001/jamanetworkopen.2020.20977 Abstract Importance Use of cannabidiol (CBD) has markedly increased in the past 5 years, concurrent...

El cannabis es la sustancia psicoactiva bajo control internacional que más se utiliza a nivel mundial. Se calcula que, en el 2013, 181,8 millones de personas de 15 a 64 años consumieron cannabis sin fines médicos en todo el mundo (estimaciones de la incertidumbre: 128,5-232,1 millones) (UNODC, 2015)...

Source: Hawke, L. D., Wilkins, L., & Henderson, J. (2020). Early cannabis initiation: Substance use and mental health profiles of service-seeking youth. Journal of Adolescence, 83, 112-121. Abstract Introduction Early cannabis use is associated with mental health and substance use (MHSU) challenges...

Source: Vink, J. M., Veul, L., Abdellaoui, A., Hottenga, J. J., Boomsma, D. I., & Verweij, K. J. (2020). Illicit Drug Use and the Genetic Overlap with Cannabis Use. Drug and Alcohol Dependence, 108102. Highlights •Lifetime prevalence: cannabis 24.8 %. •ecstacy 6.2 %, stimulants 6.5 % and any illicit...

Fuente: Contreras, A. E. R., Ortega-Mora, I., Belmont, O. A., Díaz, M. M., & García, Ó. P. (2016). Mariguana y sus efectos sobre el cerebro, la toma de decisiones y la inteligencia. Una revisión narrativa. Revista inteRnacional de investigación en adicciones, 2(2), 46-56. Resumen Introducción: la...

Source: Scherma, M., Qvist, J. S., Asok, A., Shao-shan, C. H., Masia, P., Deidda, M., ... & Kandel, E. R. (2020). Cannabinoid exposure in rat adolescence reprograms the initial behavioral, molecular, and epigenetic response to cocaine. Proceedings of the National Academy of Sciences. Abstract The...

Source: Bahji A, Stephenson C, Tyo R, Hawken ER, Seitz DP. Prevalence of Cannabis Withdrawal Symptoms Among People With Regular or Dependent Use of Cannabinoids: A Systematic Review and Meta-analysis. JAMA Netw Open. 2020;3(4):e202370. doi:10.1001/jamanetworkopen.2020.2370 Key Points Questions What...

Marijuana is the illegal drug most consumed in Peru and gender-specific predictors have not yet been identified in the general population. This information will be relevant for increasing the knowledge of processes involved in marijuana use. This research has the objective of identifying gender...

Source: Hindley, G., Beck, K., Borgan, F., Ginestet, C. E., McCutcheon, R., Kleinloog, D., ... & Howes, O. D. (2020). Psychiatric symptoms caused by cannabis constituents: a systematic review and meta-analysis. The Lancet Psychiatry. Summary Background Approximately 188 million people use cannabis...

Source: Volkow, N. D., & Weiss, S. R. (2020). Importance of a standard unit dose for cannabis research. Addiction. A standardized measure for 9‐tetrahydrocannabinol (THC) content in cannabis products is necessary to advance research both on the adverse effects of cannabis (e.g. risks for brain...

Source: Pedersen ER, Firth C, Parker J, Shih RA, Davenport S, Rodriguez A, Dunbar MS, Kraus L, Tucker JS, D'Amico EJ. Locating Medical and Recreational Cannabis Outlets for Research Purposes: Online Methods and Observational Study. J Med Internet Res 2020;22(2):e16853 DOI: 10.2196/16853 ABSTRACT...

Fuente: Espinosa, E. O., Polo, A. L., Guàrdia, M. G., Ogué, M. C. P., Folgar, M. I., & Arnedillo, J. J. M. (2018). ¿ Por qué y cómo tener en cuenta al cannabis en nuestros pacientes fumadores?. Atención Primaria. RESUMEN El Proyecto ÉVICT (Evictproject.org), a raíz del aumento de consumo de cannabis...

Fuente: Millán-Guerrero, R. O., & Isais-Millán, S. (2019). Cannabis y los sistemas exocannabinoide y endocannabinoide. Su uso y controversias. Gaceta medica de Mexico, 155(5), 508-512. Resumen El cannabis (marihuana) es una de las sustancias psicoactivas más consumidas en el mundo. El término...

Source: Busquets-Garcia, A., Bains, J. & Marsicano, G. CB1 Receptor Signaling in the Brain: Extracting Specificity from Ubiquity. Neuropsychopharmacol. 43, 4–20 (2018). https://doi.org/10.1038/npp.2017.206 Abstract Endocannabinoids (eCBs) are amongst the most ubiquitous signaling molecules in the...

Source: Li, G., Chihuri, S. Is marijuana use associated with decreased use of prescription opioids? Toxicological findings from two US national samples of drivers. Subst Abuse Treat Prev Policy 15, 12 (2020). https://doi.org/10.1186/s13011-020-00257-7 Abstract Background State governments in the...